Aljuaid Nada Mohammed, Muharram Ebtesam Ibrahim, Loqtum Nouf Nasser, Al-Amoudi Reem Mohammed, AlMahdi Hadiah Bassam, Salama Mohammed Assem, Banaganapalli Babajan, Shaik Noor Ahmad, Elango Ramu, Bondagji Nabeel Salem
Department of Biological Sciences, Faculty of Science, University of Jeddah, Jeddah, Saudi Arabia.
Department of Biological Sciences, Faculty of Science, King Abdulaziz University, Jeddah, Saudi Arabia.
Saudi J Med Med Sci. 2020 Sep-Dec;8(3):174-180. doi: 10.4103/sjmms.sjmms_280_19. Epub 2020 Aug 20.
The objective of this study was to investigate the association of rs1051740, rs2234922 (in ), rs268 (in ) and rs6025 (in ) genetic variants with the risk of preeclampsia development in Saudi women.
This case-control study recruited 233 Saudi women (94 preeclampsia cases and 139 healthy controls) who visited the Gynecology and Obstetrics Departments of two hospitals in Jeddah, Saudi Arabia, for routine postpregnancy clinical follow-ups. All the women underwent thorough clinical and biochemical investigations conducted according to the standard clinical guidelines. Genotyping of the study participants was done using real-time polymerase chain reaction-based TaqMan allelic discrimination assay. The strength of the association between genetic variants and disease development was assessed using chi-square, odds ratio, 95% confidence interval and multifactor dimensionality reduction tests.
The minor alleles "G" in rs268 () and "A" in rs6025 () were absent in Saudi women. The frequencies of rs1051740 and rs2234922 of , both in the homozygous and allelic forms, were not significantly different between preeclampsia patients and healthy controls (for all tests, > 0.05). The multifactor dimensionality reduction analysis also indicated that the interaction between the four studied single-nucleotide polymorphisms (SNPs) had no significant association with preeclampsia risk.
This study found that none of the studied genetic variants (neither the single SNP nor the SNP-SNP interactions) explain the development of preeclampsia in the Saudi population. These findings not only underscore the disease heterogeneity but also highlight the need to develop population-specific diagnostic genetic biomarkers for preeclampsia.
本研究旨在调查rs1051740、rs2234922(位于 )、rs268(位于 )和rs6025(位于 )基因变异与沙特女性发生先兆子痫风险之间的关联。
本病例对照研究招募了233名沙特女性(94例先兆子痫患者和139名健康对照),她们前往沙特阿拉伯吉达市两家医院的妇产科进行产后常规临床随访。所有女性均按照标准临床指南进行了全面的临床和生化检查。研究参与者的基因分型采用基于实时聚合酶链反应的TaqMan等位基因鉴别分析。使用卡方检验、比值比、95%置信区间和多因素降维检验评估基因变异与疾病发生之间的关联强度。
沙特女性中不存在rs268( )的次要等位基因“G”和rs6025( )的次要等位基因“A”。rs1051740和rs2234922 的纯合子和等位基因形式在先兆子痫患者和健康对照之间的频率无显著差异(所有检验, >0.05)。多因素降维分析还表明,所研究的四个单核苷酸多态性(SNP)之间的相互作用与先兆子痫风险无显著关联。
本研究发现,所研究的基因变异(无论是单个SNP还是SNP-SNP相互作用)均无法解释沙特人群中先兆子痫的发生。这些发现不仅强调了疾病的异质性,还突出了开发针对先兆子痫的人群特异性诊断基因生物标志物的必要性。